FDA backs new cervical cancer vaccine Cervarix - Sexual health- msnbc.com

Links shared publicly online about this topic.

  • 1,761
    total visits

FDA backs new cervical cancer vaccine Cervarix - Sexual health- msnbc.com

msnbc.msn.com

Federal health officials favor approving GlaxoSmithKline's long-delayed vaccine Cervarix to prevent the leading cause of cervical cancer in U.S. women.

View full resource at msnbc.msn.com

Tags: Cervical Cancer Prevention, Sex and Intimacy, Women's Health, FDA, Vaccine, HPV Vaccine, Cervarix, GlaxoSmithKline

  • Share

Most Recently Shared on September 9, 2009 at 7:07 pm By:

OncologySupport Oncology Institute

RT @msnbc_health FDA backs new cervical cancer vaccine Cervarix http://bit.ly/VTzE3

3 years ago...

Also Shared By:

msnbc.com - Health msnbc.com - Health

LHJ Health Editors LHJ Health Editors

FDA approves second cervical cancer vaccine, Cervarix, for preventing HPV in women

nydailynews.com — “Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women.View full resource at nydailynews.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 3:34 pm By:

NYDNlifestyle NYDN Lifestyle Health Site

FDA backs new HPV vaccine, Cervarix: Federal health officials said Wednesday a long-delayed vaccine from GlaxoSm.. http://bit.ly/30QPTi

3 years ago...

Advertisement